ALIYA SHEIK

Dr. ALIYA SHEIK

INHA University, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2012 in Integrative Biology
Verified
Journal Article
Closed access
PDF file
PGPurnachandra N Ganji
Purnachandra N Ganji
ASALIYA SHEIK
ALIYA SHEIK
SZSyed F. Zafar
Syed F. Zafar
RBRiyaz Basha
Riyaz Basha
RDRoberto Diaz
Roberto Diaz
BEBassel F. El-Rayes
Bassel F. El-Rayes
The inhibition of human breast cancer cell growth by curcumin is mediated via signaling cascades including the NF-κB pathway. Epidemiological and experimental d

1 October 2016 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
PGPurnachandra N Ganji
Purnachandra N Ganji
BRBalney Rajitha
Balney Rajitha
ASALIYA SHEIK
ALIYA SHEIK
RKRama P. Kotipatruni
Rama P. Kotipatruni
AMAppiya Santharam Madanraj
Appiya Santharam Madanraj
SPSubasini Pattnaik
Subasini Pattnaik

18 April 2021 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
GCGayathri Chalikonda
Gayathri Chalikonda
HLHoomin Lee
Hoomin Lee
ASALIYA SHEIK
ALIYA SHEIK
YHYun Suk Huh
Yun Suk Huh

1 February 2015 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
PGPurnachandra N Ganji
Purnachandra N Ganji
ASALIYA SHEIK
ALIYA SHEIK
OAOlatunji Boladale Alese
Olatunji Boladale Alese

26 January 2022
Verified
Journal Article
Open access
PDF file
ASALIYA SHEIK
ALIYA SHEIK
HLHoomin Lee
Hoomin Lee
MAMunirah Alhammadi
Munirah Alhammadi
URUmapathi Reddicherla
Umapathi Reddicherla
YHYun Suk Huh
Yun Suk Huh
Hepatocellular carcinoma is a primary liver cancer caused by the accumulation of genetic mutation patterns associated with epidemiological conditions. This lethal malignancy exhibits tumor heterogeneity, which is considered as one of the main reasons for drug resistance development and failure of clinical trials. Recently, single-cell technology (SCT), a new advanced sequencing technique that analyzes every single cell in a tumor tissue specimen, aids complete insight into the genetic heterogeneity of cancer. This helps in identifying and assessing rare cell populations by analyzing the difference in gene expression pattern between individual cells of single biopsy tissue which normally cannot be identified from pooled cell gene expression pattern (traditional sequencing technique). Thus, SCT improves the clinical diagnosis, treatment, and prognosis of hepatocellular carcinoma as the limitations of other techniques impede this cancer research progression. Application of SCT at the genomic, transcriptomic, and epigenomic levels to promote individualized hepatocellular carcinoma diagnosis and therapy. The current review has been divided into ten sections. Herein we deliberated on the SCT, hepatocellular carcinoma diagnosis, tumor microenvironment analysis, single-cell genomic sequencing, single-cell transcriptomics, single-cell omics sequencing for biomarker development, identification of hepatocellular carcinoma origination and evolution, limitations, challenges, conclusions, and future perspectives.

27 September 2023 in Microchemical Journal
Verified
Journal Article
Closed access
MAMunirah Alhammadi
Munirah Alhammadi
ASALIYA SHEIK
ALIYA SHEIK
RUReddicherla Umapathi
Reddicherla Umapathi
MOMi-Hwa Oh
Mi-Hwa Oh
YHYun Suk Huh
Yun Suk Huh